Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessWhy Did Palantir Shares Plunge 11 percent Yesterday?

Why Did Palantir Shares Plunge 11 percent Yesterday?

Add to Favorite
Added to Favorite


Palantir (NYSE:PLTR) shares fell more than 11% on Monday following the company’s reported its slowest quarterly revenue growth since it went public in 2020.
Q3 EPS came in at $0.01, missing the Street estimate of $0.03. Revenue was $478 million, compared to the Street estimate of $474.66 million. Strong US government contracting activity (approximately $1 billion in TCV) was the highlight in the quarter; however, given its lumpy nature and a mix of funded and unfunded contracts within total deal value the timing of when this will translate into revenue is less clear.
For Q4/22, the company expects revenue to be in the range of $503-505 billion, compared to the Street estimate of $502.7 billion. Analysts at Deutsche Bank lowered their price target to $7 from $8 following the earnings announcement. Until having a greater line of sight to revenue growth troughing and a more meaningful improvement in operating margins back toward prior-year levels, the analysts said they will keep their Sell rating.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Lifecore Biomedical, Inc. (NASDAQ: LFCR) Quarterly Earnings Preview

Earnings per Share (EPS) loss is anticipated to be...

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Faces Financial Challenges

Earnings per Share (EPS) of -$0.07 missed the estimated...

Arthur J. Gallagher & Co. (NYSE: AJG) Insider Purchase and Stock Performance

Gallagher Patrick Murphy, COO of Arthur J. Gallagher &...